Double blind study using amantadine hydrochloride in the therapy of Parkinson's disease
Silver, D.E.; Sahs, A.L.
Transactions of the American Neurological Association 96: 307-308
1971
ISSN/ISBN: 0065-9479 PMID: 4945919 Document Number: 41674
Document emailed within 1 workday
Related Documents
Muenter, M.D. 1970: Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease Neurology 20(12 Suppl): 6-13Griffiths, A.V.; Parker, W.N.; Palmer, R.M. 1971: Experiences with amantadine hydrochloride in Parkinson's disease Practitioner 207(241): 679-680
Gospavić, J.; Vidaković, Z. 1974: Effectiveness of a combination therapy in the Parkinson syndrome by amantadine hydrochloride and anticholinergic agents Srpski Arhiv Za Celokupno Lekarstvo 102(6): 447-457
Olanow, C.W.; Alberts, M.J. 1987: Double-blind controlled study of pergolide mesylate as an adjunct to Sinemet in the treatment of Parkinson's disease Advances in Neurology 45: 555-560
Danielczyk, W. 1995: Twenty-five years of amantadine therapy in Parkinson's disease Journal of Neural Transmission. Supplementum 46: 399-405
Dzudza, M.; Dzudza, D. 1974: Comparative study on Parkopan, Amantadine and L-dopa in the treatment of Parkinson's disease Medicinski Arhiv 28(4): 407-415
Amarapurkar, D.N.; Rane, P. 2004: Randomised, double-blind, comparative study to evaluate the efficacy and safety of ganaton (itopride hydrochloride) and mosapride citrate in the management of functional dyspepsia Journal of the Indian Medical Association 102(12): 735
Campbell, A.M.; Williams, M.J. 1972: Trial of amantadine in Parkinson's disease British Journal of Clinical Practice 26(1): 19-22
Nakamura, H.; Uyama, H.; Enomoto, H.; Kishima, Y.; Yamamoto, M.; Yoshida, K.; Okuda, Y.; Hirotani, T.; Kuroda, T.; Ito, H.; Matsuda, M.; Terabayashi, M.; Noguchi, S. 2003: The combination therapy of interferon and amantadine hydrochloride for patients with chronic hepatitis C Hepato-Gastroenterology 50(49): 222-226
Pendefunda, G.; Pollingher, B.; Stefanache, F.; Gavril, A.; Oprisan, C.; Merling, M.; Nemteanu, E.; Ciunru, M.; Koropitzer, I. 1975: The treatment with L-dopa and amantadine in Parkinson's disease Therapia Hungarica 23(1): 12-16
Fasano, V.A.; Urciuoli, R.; Broggi, G. 1971: On the treatment of Parkinson's disease with intravenous administration of amantadine (77 cases) Minerva Medica 62(82): 3968-3970
Merrick, E.M.; Schmitt, P.P. 1973: A controlled study of the clinical effects of amantadine hydrochloride (Symmetrel) Current Therapeutic Research 15(8): 552-558
Zeitler, E. 1976: Xenon-133 muscle clearance before and after butalamine hydrochloride. Results of a double blind test Fortschritte der Medizin 94(34): 2055-2058
Aktulga, E.; Altaç, M.; Müftüoglu, A.; Ozyazgan, Y.; Pazarli, H.; Tüzün, Y.; Yalçin, B.; Yazici, H.; Yurdakul, S. 1980: A double blind study of colchicine in Behçet's disease Haematologica 65(3): 399-402
Van der Rijt, C.C.; Schalm, S.W.; Meulstee, J.; Stijnen, T. 1995: Flumazenil therapy for hepatic encephalopathy. a double-blind cross over study Gastroenterologie Clinique et Biologique 19(6-7): 572-580
Debelic, M.; Radielovic, P. 1973: Therapy of banal rhinitis. Double-blind controlled clinical study Schweizerische Rundschau für Medizin Praxis 62(35): 1074-1077
Montgomery, B.A.; Cullinan, T.R.; Bayley, A.J. 1970: A double-blind comparative trial of doxepin hydrochloride and chlordiazepoxide in anxiety and depression in general practice British Journal of Clinical Practice 24(5): 207-209
Antuono, P.G. 1995: Effectiveness and safety of velnacrine for the treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Mentane Study Group Archives of Internal Medicine 155(16): 1766-1772
Lachnit-Fixson, U.; Kaufmann, J. 1977: Therapy of androgenization symptoms: double blind study of an antiandrogen preparation (SH B 209 AB) against neogynon Medizinische Klinik 72(45): 1922-1926
Bouzo, H. 1979: Diagnosis and therapy of peptic ulcer. Clinical report with double-blind study Die Medizinische Welt 30(25): 979-984